journal
MENU ▼
Read by QxMD icon Read
search

Journal of Ovarian Research

journal
https://www.readbyqxmd.com/read/30012201/fresh-versus-frozen-embryo-transfer-for-full-term-singleton-birth-a-retrospective-cohort-study
#1
Junwei Zhang, Mingze Du, Zhe Li, Lulu Wang, Jijun Hu, Bei Zhao, Yingying Feng, Xiaolin Chen, Lijun Sun
BACKGROUND: Improvements in vitrification and frozen embryo transfer (FET) technologies have rapidly increased, and some evidence suggests that FET may increase pregnancy rates and lead to more favourable perinatal outcomes. However, the outcome of interest should be offspring safety. Therefore, the primary objective of our study was to investigate whether FET was preferable to fresh embryo transfer (ET) in terms of full-term neonatal birthweight and congenital malformations. METHODS: This was a retrospective cohort study of patients with no pregnancy-related complications who underwent first fresh ETs (n = 2059) or FETs (n = 2053), resulting in full-term singletons births...
July 16, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/30012195/discordant-anti-m%C3%A3-llerian-hormone-amh-and-follicle-stimulating-hormone-fsh-among-women-undergoing-in-vitro-fertilization-ivf-which-one-is-the-better-predictor-for-live-birth
#2
Shunping Wang, Yi Zhang, Virginia Mensah, Warren J Huber, Yen-Tsung Huang, Ruben Alvero
BACKGROUND: This study sought to clarify the roles of Anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) in predicting live birth, especially in patients with discordant AMH and FSH. A large IVF data set provided by eIVF®, consisting of 13,964 cycles with AMH, FSH, age, BMI, and birth outcomes were evaluated. Patients were categorized into four groups: Good prognosis group (AMH ≥1 ng/ml; FSH < 10 mIU/ml), Poor prognosis group (AMH < 1 ng/ml; FSH ≥10 mIU/ml), Reassuring AMH group (AMH ≥1 ng/ml; FSH ≥10 mIU/ml), and Reassuring FSH group (AMH < 1 ng/ml; FSH < 10 mIU/ml)...
July 16, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29986747/establishment-and-molecular-characterization-of-a-human-ovarian-clear-cell-carcinoma-cell-line-fdov1
#3
Wei Jiang, Shuang Ye, Libing Xiang, Wentao Yang, Tiancong He, Xuan Pei, Lin Guo, Huijuan Yang
BACKGROUND: Ovarian clear cell carcinoma is a distinct histologic subtype with grave survival. The underlying molecular mechanism is not fully elucidated. However, we don't have many cell lines, which are useful experimental tools for research. We describe the establishment and characterization of a new ovarian clear cell carcinoma cell line from a Chinese patient. RESULTS: FDOV1 has been subcultured for more than 80 generations. Monolayer cultured cells are polygonal in shape, showing a transparent cytoplasm full of vacuoles...
July 9, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29976256/expression-of-concern-to-does-ovary-need-d-chiro-inositol
#4
EDITORIAL
Rosalbino Isabella, Emanuela Raffone
No abstract text is available yet for this article.
July 5, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29973223/wounding-promotes-ovarian-cancer-progression-and-decreases-efficacy-of-cisplatin-in-a-syngeneic-mouse-model
#5
Yooyoung Lee, Alexandra Kollara, Taymaa May, Theodore J Brown
BACKGROUND: Primary cytoreductive surgery followed by adjuvant chemotherapy is the standard treatment for advanced epithelial ovarian cancer. The average interval between surgery and chemotherapy initiation is approximately 4-weeks at most centers; however, since surgery may accelerate residual tumor growth, a shorter interval may be more beneficial. METHODS: The murine ID8 cell model of ovarian cancer was used to examine the efficacy of cisplatin treatment administered perioperatively or 7 days after surgical wounding...
July 4, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29958542/effect-of-resveratrol-and-metformin-on-ovarian-reserve-and-ultrastructure-in-pcos-an-experimental-study
#6
Selenay Furat Rencber, Sema Kurnaz Ozbek, Ceyla Eraldemır, Zehra Sezer, Tugba Kum, Sureyya Ceylan, Elif Guzel
BACKGROUND: PCOS is a reproductive hormonal abnormality and a metabolic disorder. It is frequently associated with insulin resistance, hyperandrogenism, chronic inflammation, and oxidative stress. We aim to investigate the potential therapeutic effects of combined therapy of resveratrol and metformin on polycystic ovaries via SIRT1 and AMPK activation. METHODS: Wistar albino rats were divided into control and experimental (PCOS) groups. DHEA-induced PCOS rats were given resveratrol (20 mg/kg/day), metformin (300 mg/kg/day) and combined therapy...
June 29, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29958541/age-dependent-difference-in-impact-of-fertility-preserving-surgery-on-disease-specific-survival-in-women-with-stage-i-borderline-ovarian-tumors
#7
Haiyan Sun, Xi Chen, Tao Zhu, Nanfang Liu, Aijun Yu, Shihua Wang
BACKGROUND: This study was to determine age-specific impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors (BOTs). Patients diagnosed during 1988-2000 were selected from The Surveillance, Epidemiology, and End Results (SEER) database. The age-specific impact of fertility preserving surgery and other risk factors were analyzed in patients with stage I BOTs using Cox proportion hazard regression models. Data from our hospital were collected during 1996-2017 to determine the prevalence of patients who had undergone fertility preserving surgery...
June 29, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29941051/endometriosis-does-not-confer-improved-prognosis-in-ovarian-clear-cell-carcinoma-a-retrospective-study-at-a-single-institute
#8
Ting Zhao, Yu Shao, Yan Liu, Xiao Wang, Luyao Guan, Yuan Lu
BACKGROUND: Considered as the precursor lesion of a subset of ovarian clear cell carcinoma (OCCC), the prognostic role of endometriosis in OCCC patients remains controversial. This study aimed to investigate the prognostic role of coexisting endometriosis in the survival of patients with OCCC, and also sought to identify other prognostic factors. RESULTS: A total of 125 patients were diagnosed with OCCC during the study period. Of these, 55 (44.0%) patients had coexisting endometriosis...
June 26, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29933751/alpha-fetoprotein-producing-ovarian-clear-cell-adenocarcinoma-with-fetal-gut-differentiation-a-rare-case-report-and-literature-review
#9
Wei-Ting Chao, Chia-Hao Liu, Chiung-Ru Lai, Yi-Jen Chen, Chi-Mu Chuang, Peng-Hui Wang
BACKGROUND: Alpha-fetoprotein (AFP) is a useful tumor marker for ovarian germ cell tumors, particularly yolk sac tumor (YST). It is valuable for both diagnosis and further follow-up. Epithelial ovarian carcinoma (EOC) rarely secretes AFP, especially for clear cell type and in the postmenopausal women. Based on the limited knowledge about AFP-producing clear cell type EOC, a case and literature review on this topic is extensively reviewed. CASE PRESENTATION: We report a 55-year-old postmenopausal woman experienced vaginal spotting for one month, and serum level of AFP was 60,721 ng/ml initially...
June 22, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29929541/quercetin-increases-the-antioxidant-capacity-of-the-ovary-in-menopausal-rats-and-in-ovarian-granulosa-cell-culture-in-vitro
#10
Jiao Wang, Xin Qian, Qiang Gao, Chunmei Lv, Jie Xu, Hongbo Jin, Hui Zhu
BACKGROUND: Menopause is the most important sign of aging in women, and the ovary is the organ most sensitive to aging. Quercetin is a potential antioxidant and free radical scavenger that is widely found in fruits, vegetables, and leaves. However, the effect of quercetin on ovarian aging has not been elucidated, and the mechanism underlying its antioxidative effect remains unclear. The purpose of the current study was to investigate whether quercetin protects ovarian function by decreasing oxidative stress...
June 21, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29925418/dna-damage-repair-in-ovarian-cancer-unlocking-the-heterogeneity
#11
REVIEW
Mary Ellen Gee, Zahra Faraahi, Aiste McCormick, Richard J Edmondson
Treatment for advanced ovarian cancer is rarely curative; three quarters of patients with advanced disease relapse and ultimately die with resistant disease. Improving patient outcomes will require the introduction of new treatments and better patient selection. Abrogations in the DNA damage response (DDR) may allow such stratifications.A defective DNA-damage response (DDR) is a defining hallmark of high grade serous ovarian cancer (HGSOC). Indeed, current evidence indicates that all HGSOCs harbour a defect in at least one major DDR pathway...
June 20, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29914567/clinical-study-of-a-ct-evaluation-model-combined-with-serum-ca125-in-predicting-the-treatment-of-newly-diagnosed-advanced-epithelial-ovarian-cancer
#12
Lu Qin, Huming Huang, Mengjie Chen, Yuejuan Liang, He Wang
BACKGROUND: The treatment of newly diagnosed advanced epithelial ovarian cancer (EOC) was predicted by an ovarian cancer computed tomography (CT) evaluation model combined with serum CA125. METHODS: Clinical data for 194 patients with advanced EOC treated with neoadjuvant chemotherapy (NACT) combined with interval debulking surgery (IDS) or primary debulking surgery (PDS) were retrospectively analyzed, and the appropriate treatment was predicted by comparing the subgroup differences in intraoperative situations, postoperative situations and survival rates...
June 18, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29914564/consanguineous-familial-study-revealed-biallelic-figla-mutation-associated-with-premature-ovarian-insufficiency
#13
Beili Chen, Lin Li, Jing Wang, Tengyan Li, Hong Pan, Beihong Liu, Yiran Zhou, Yunxia Cao, Binbin Wang
BACKGROUND: To dissect the genetic alteration in two sisters with premature ovarian insufficiency (POI) from a consanguineous family. METHODS: Whole-exome sequencing technology was used in the POI proband, bioinformatics analysis was carried out to identify the potential genetic cause in this pedigree. Sanger sequencing analyses were performed to validate the segregation of the variant within the pedigree. In silico analysis was also used to predict the effect and pathogenicity of the variant...
June 18, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29903044/he4-level-in-ascites-may-assess-the-ovarian-cancer-chemotherapeutic-effect
#14
Duanyang Liu, Dan Kong, Jing Li, Lei Gao, Di Wu, Yu Liu, Weiwei Yang, Lei Zhang, Jiang Zhu, Xiaoming Jin
BACKGROUND: The clinical treatment of ovarian cancer with ascites is problematic. The main reasons for treatment failure are the susceptibility to intraperitoneal metastasis and chemotherapeutic drug resistance. The purpose and significance of this study is to evaluate which marker might evaluate treatment efficacy and improve the cure rate. RESULTS: This study compared a no chemotherapy group with a chemotherapy group regarding the determination of carbohydrate antigen 125 and human epididymis protein 4 in ovarian cancer ascitic supernatants and cross-analyzed routine serum carbohydrate antigen 125 levels...
June 14, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29871662/mr-findings-of-primary-ovarian-granulosa-cell-tumor-with-focus-on-the-differentiation-with-other-ovarian-sex-cord-stromal-tumors
#15
He Zhang, Hongyu Zhang, Shouxin Gu, Yanyu Zhang, Xuefen Liu, Guofu Zhang
BACKGROUND: To describe magnetic resonance imaging (MRI) features of ovarian granulosa cell tumors (OGCTs) and compare with other sex cord-stromal tumors (OSCs) in ovary. METHODS: MR findings of 18 patients with surgically confirmed ovarian granulosa cell tumor were retrospectively reviewed by two radiologists with consensus reading. All MR examinations were prospectively performed within one month. Clinical and imaging characteristics of OGCTs were evaluated and compared with OSCs (control group)...
June 5, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29859107/comparison-of-the-influence-of-three-fibroid-treatment-options-supracervical-hysterectomy-ulipristal-acetate-and-uterine-artery-embolization-on-ovarian-reserve-an-observational-study
#16
Piotr Czuczwar, Anna Stepniak, Pawel Milart, Tomasz Paszkowski, Slawomir Wozniak
BACKGROUND: To assess and compare the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve. METHODS: Prospective, observational, open-label study performed at the 3rd Chair and Department of Gynecology of the Medical University of Lublin, Poland. Premenopausal Caucasian women with symptomatic uterine fibroids were recruited into 3 groupspatients qualified for supracervical hysterectomies; patients qualified for preoperative ulipristal acetate (UPA) treatment scheduled for supracervical hysterectomies or myomectomies; patients qualified for uterine artery embolization (UAE)...
June 1, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29848369/superficially-invasive-cervical-squamous-cell-carcinoma-metastatic-to-ovarian-endometriotic-cyst-wall-a-case-report-and-brief-review-of-the-literature
#17
Minfen Zhang, Elena Lucas, Hanzhen Xiong, Shaoyan Liu, Kyle Molberg, Qingping Jiang, Wenxin Zheng
BACKGROUND: Although cases of cervical squamous cell carcinoma metastatic to the ovary have been previously documented, we report the first case of superficially invasive squamous cell carcinoma metastatic to the ovary. CASE PRESENTATION: A 45-year-old woman with a two-year history of ovarian endometriosis confirmed by ultrasound underwent oophorectomy. On microscopic examination, a focus of malignant stratified epithelium, initially interpreted as transitional cell carcinoma, was identified within the endometriotic cyst wall...
May 30, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29843813/stratification-of-ovarian-tumor-pathology-by-expression-of-programmed-cell-death-1-pd-1-and-pd-ligand-1-pd-l1-in-ovarian-cancer
#18
Maureen L Drakes, Swati Mehrotra, Monica Aldulescu, Ronald K Potkul, Yueying Liu, Anne Grisoli, Cara Joyce, Timothy E O'Brien, M Sharon Stack, Patrick J Stiff
BACKGROUND: Ovarian cancer is the major cause of death among gynecologic cancers with 75% of patients diagnosed with advanced disease, and only 20% of these patients having a survival duration of five years. Treatments blocking immune checkpoint molecules, programmed cell death (PD-1) or its ligand PD-ligand- I (PD-L1) have produced a beneficial and prolonged effect in a subgroup of these patients. However, there is debate in the literature concerning the prognostic value of the expression of these molecules in tumors, with immunotherapy responsiveness, and survival...
May 30, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29843747/a-predictive-score-for-optimal-cytoreduction-at-interval-debulking-surgery-in-epithelial-ovarian-cancer-a-two-centers-experience
#19
Eleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, Massimo Aglietta, Marco Vaira, Michele De Simone, Gloria Mittica, Gaia Giannone, Manuela Robella, Sofia Genta, Fabiola Lucchino, Francesco Marocco, Fulvio Borella, Giorgio Valabrega, Riccardo Ponzone
BACKGROUND: Optimal cytoreduction (macroscopic Residual Tumor, RT = 0) is the best survival predictor factor in epithelial ovarian cancer (EOC). It doesn't exist a consolidated criteria to predict optimal surgical resection at interval debulking surgery (IDS). The aim of this study is to develop a predictive model of complete cytoreduction at IDS. METHODS: We, retrospectively, analyzed 93 out of 432 patients, with advanced EOC, underwent neoadjuvant chemotherapy (NACT) and IDS from January 2010 to December 2016 in two referral cancer centers...
May 30, 2018: Journal of Ovarian Research
https://www.readbyqxmd.com/read/29843765/clinical-analysis-of-chemo-resistance-risk-factors-in-endometriosis-associated-ovarian-cancer
#20
Tong Ren, Ting-Ting Sun, Shu Wang, Jian Sun, Yang Xiang, Keng Shen, Jing-He Lang
BACKGROUND: To analyze the clinical characteristics and chemo-resistance related factors of patients with resistant and non-resistant endometriosis-associated ovarian cancer (ovarian clear cell carcinoma and endometrioid carcinoma) by reviewing the data of epithelial ovarian cancer patients who received initial treatment in our hospital over a 12-year period. RESULTS: Among the 304 patients, 17.1% were seen with platinum-based drug resistance. The ROC curve of continuous variables was drawn according to resistance situation, then they were grouped by age (< 48 or ≥ 48 years), tumor size (< 7 cm or ≥ 7 cm) and Ca125 (< 90 and ≥ 90 U/ml)...
May 29, 2018: Journal of Ovarian Research
journal
journal
42004
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"